Lipella Pharmaceuticals Inc. (LIPO:NASDAQ) rocketted at $2.09, representing a gain of 34.8%. On Fri, Oct 20, 2023, LIPO:NASDAQ hit a New 2-Week High of $2.09. The stock appeared on our News Catalysts scanner on Fri, Oct 20, 2023 at 08:48 AM in the 'BIOTECH' category. From Fri, Oct 06, 2023, the stock recorded 60.00% Up Days and 63.64% Green Days
The stock spiked on Fri, Oct 20, 2023 at $2.71 with a volume of 45M+.
About Lipella Pharmaceuticals Inc. (LIPO:NASDAQ)
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company's lead product includes LP-10 and LP-310.
Top 10 Gainers:
- XORTX Therapeutics Inc. (XRTX:NASDAQ), 100.63%
- Golden Minerals Company (AUMN:NYSEMKT), 49.61%
- Wang & Lee Group Inc. (WLGS:NASDAQ), 38.69%
- Nouveau Monde Graphite Inc. (NMG:NYSE), 36.63%
- Universal Security Instruments, Inc. (UUU:NYSEMKT), 36.11%
- Bio-Path Holdings, Inc. (BPTH:NASDAQ), 35.32%
- Lipella Pharmaceuticals Inc. (LIPO:NASDAQ), 34.84%
- Aravive, Inc. (ARAV:NASDAQ), 31.75%
- FLJ Group Limited (FLJ:NASDAQ), 31.05%
- Northann Corp. (NCL:NYSEMKT), 30.43%